Literature DB >> 35110042

Efficacy of Palonosetron and Dexamethasone for Prevention of Post-operative Nausea and Vomiting in Female Patients Undergoing Laparoscopic Cholecystectomy: A Prospective Randomised Double-Blind Trial.

Mohd Atesham Khan1, Anju Gupta2, Nishkarsh Gupta3, Manasij Mitra4.   

Abstract

OBJECTIVE: Post-operative nausea and vomiting is a frequent complication following anaesthesia. We compared the efficacy and safety of intravenous palonosetron and intravenous dexamethasone as prophylactic antiemetic in patients undergoing laparoscopic cholecystectomy.
METHODS: After obtaining institutional ethical committee approval, 100 adult female patients undergoing laparoscopic cholecystectomy were randomised to receive 4mg dexamethasone (group I, n ¼ 50) or 0.075 mg palonosetron (group II, n ¼ 50) intravenously (IV) over 2-5 minutes prior to induction of anaesthesia. Standard anaesthetic technique was followed, and the residual neuromuscular block was antagonised at theend of the procedure. A single anaesthesiologist assessed all the cases for post-operative nausea and vomiting (PONV) for 24 hours. The complete response rate and the overall patient satisfaction were noted. If patient experienced PONV, injection metoclopramide 10 mg was given as rescue antiemetic IV.
RESULTS: A total of six patients had vomiting within 6 hours (four patients in groups I and two patients in group II), whereas none had vomiting after 6 hours (P ¼ .39). Complete response rate was 88 and 90% in both group I and group II. Three patients in both group I and group II required rescue antiemetics. Ninety-two percent patients were completely satisfied in group I, while 96% patients were fully satisfied in group II.
CONCLUSION: Intravenous administration of palonosetron (0.075 mg) is as effective as dexamethasone (4 mg) as prophylactic antiemetic without any untoward side effects for female patients undergoing laparoscopic cholecystectomy.

Entities:  

Year:  2021        PMID: 35110042      PMCID: PMC9053691          DOI: 10.5152/TJAR.2021.191

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN: 2149-276X


  21 in total

1.  A randomized double blind study to evaluate efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of postoperative and postdischarge nausea and vomiting in subjects undergoing laparoscopic surgeries with high emetogenic risk.

Authors:  Jeanna D Blitz; Michael Haile; Richard Kline; Lola Franco; Sorosch Didehvar; H Leon Pachter; Elliot Newman; Alex Bekker
Journal:  Am J Ther       Date:  2012-09       Impact factor: 2.688

2.  Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study.

Authors:  Y E Moon; J Joo; J E Kim; Y Lee
Journal:  Br J Anaesth       Date:  2012-01-25       Impact factor: 9.166

3.  Consensus guidelines for the management of postoperative nausea and vomiting.

Authors:  Tong J Gan; Pierre Diemunsch; Ashraf S Habib; Anthony Kovac; Peter Kranke; Tricia A Meyer; Mehernoor Watcha; Frances Chung; Shane Angus; Christian C Apfel; Sergio D Bergese; Keith A Candiotti; Matthew Tv Chan; Peter J Davis; Vallire D Hooper; Sandhya Lagoo-Deenadayalan; Paul Myles; Greg Nezat; Beverly K Philip; Martin R Tramèr
Journal:  Anesth Analg       Date:  2014-01       Impact factor: 5.108

4.  Dexamethasone decreases vomiting by children after tonsillectomy.

Authors:  W M Splinter; D J Roberts
Journal:  Anesth Analg       Date:  1996-11       Impact factor: 5.108

5.  Impact of antiemetic selection on postoperative nausea and vomiting and patient satisfaction.

Authors:  T Darkow; M L Gora-Harper; D T Goulson; K E Record
Journal:  Pharmacotherapy       Date:  2001-05       Impact factor: 4.705

Review 6.  An update on the management of postoperative nausea and vomiting.

Authors:  Xuezhao Cao; Paul F White; Hong Ma
Journal:  J Anesth       Date:  2017-04-28       Impact factor: 2.078

7.  Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function.

Authors:  Camilo Rojas; Ajit G Thomas; Jesse Alt; Marigo Stathis; Jie Zhang; Edward B Rubenstein; Silvia Sebastiani; Sergio Cantoreggi; Barbara S Slusher
Journal:  Eur J Pharmacol       Date:  2009-10-15       Impact factor: 4.432

8.  Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer.

Authors: 
Journal:  N Engl J Med       Date:  1995-01-05       Impact factor: 91.245

Review 9.  Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.

Authors:  Preet Mohinder Singh; Anuradha Borle; Divakara Gouda; Jeetinder Kaur Makkar; Mahesh K Arora; Anjan Trikha; Ashish Sinha; Basavana Goudra
Journal:  J Clin Anesth       Date:  2016-06-28       Impact factor: 9.452

10.  Efficacy of Palonosetron-Dexamethasone Combination Versus Palonosetron Alone for Preventing Nausea and Vomiting Related to Opioid-Based Analgesia: A Prospective, Randomized, Double-blind Trial.

Authors:  Eunah Cho; Do-Hyeong Kim; Seokyung Shin; Seung Hyun Kim; Young Jun Oh; Yong Seon Choi
Journal:  Int J Med Sci       Date:  2018-06-13       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.